I-Mab Biopharma
IMAB
#9317
Rank
C$91.6 M
Marketcap
$1.12
Share price
-5.65%
Change (1 day)
-54.27%
Change (1 year)

I-Mab Biopharma (IMAB) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : C$15.97 Million

According to I-Mab Biopharma's latest financial reports the company's total liabilities are C$15.97 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

I-Mab Biopharma - Total liabilities on balance sheet (from 2024 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$23.68 M-28.63%
2022-12-31C$33.18 M1.54%
2021-12-31C$32.68 M54.57%
2020-12-31C$21.14 M-79.02%
2019-12-31C$0.10 B5.09%
2018-12-31C$95.91 M144.52%
2017-12-31C$39.22 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$16.85 M 5.53%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.15 B 7,146.22%๐Ÿ‡บ๐Ÿ‡ธ USA